These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1588179)

  • 1. The role of complement in the host's defense against Haemophilus influenzae.
    Winkelstein JA; Moxon ER
    J Infect Dis; 1992 Jun; 165 Suppl 1():S62-5. PubMed ID: 1588179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in the host's defense against Streptococcus pneumoniae.
    Winkelstein JA
    Rev Infect Dis; 1981; 3(2):289-98. PubMed ID: 7020046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated serum activities against genetically defined capsular transformants of Haemophilus influenzae.
    Swift AJ; Moxon ER; Zwahlen A; Winkelstein JA
    Microb Pathog; 1991 Apr; 10(4):261-9. PubMed ID: 1895927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against
    Muri L; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G; Ispasanie E
    Front Immunol; 2022; 13():1020580. PubMed ID: 36578495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
    Jönsson G; Hansson C; Mellhammar L; Gullstrand B; Bengtsson AA; Sahl C; Skattum L
    Vaccine; 2021 Feb; 39(8):1297-1302. PubMed ID: 33509693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of C3 and C4 with Haemophilus influenzae.
    Cates KL; Lockman J; Densen P; Levine RP
    J Infect Dis; 1992 Jun; 165 Suppl 1():S70-1. PubMed ID: 1588182
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae interacts with the human complement inhibitor factor H.
    Hallström T; Zipfel PF; Blom AM; Lauer N; Forsgren A; Riesbeck K
    J Immunol; 2008 Jul; 181(1):537-45. PubMed ID: 18566420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal activity against Haemophilus influenzae.
    Gordon DL
    Pathology; 1988 Apr; 20(2):124-9. PubMed ID: 3264903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae and the complement system.
    Hallström T; Riesbeck K
    Trends Microbiol; 2010 Jun; 18(6):258-65. PubMed ID: 20399102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.
    Rosadini CV; Ram S; Akerley BJ
    Infect Immun; 2014 Feb; 82(2):640-9. PubMed ID: 24478079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.
    Noel GJ; Katz S; Edelson PJ
    J Infect Dis; 1988 Jan; 157(1):85-90. PubMed ID: 3257245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.
    Crosson FJ; Winkelstein JA; Moxon ER
    Infect Immun; 1976 Oct; 14(4):882-7. PubMed ID: 1086832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Haemophilus influenzae factor H-Binding lipoprotein involved in serum resistance.
    Fleury C; Su YC; Hallström T; Sandblad L; Zipfel PF; Riesbeck K
    J Immunol; 2014 Jun; 192(12):5913-23. PubMed ID: 24835392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
    Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
    Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
    Jönsson G; Lood C; Gullstrand B; Holmström E; Selander B; Braconier JH; Sturfelt G; Bengtsson AA; Truedsson L
    Clin Immunol; 2012 Sep; 144(3):214-27. PubMed ID: 22842196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae.
    Noel GJ; Brittingham A; Granato AA; Mosser DM
    Infect Immun; 1996 Nov; 64(11):4769-75. PubMed ID: 8890238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and the host's defense against the pneumococcus.
    Winkelstein JA
    Crit Rev Microbiol; 1984; 11(3):187-208. PubMed ID: 6391822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.
    Oerlemans MMP; Moons SJ; Heming JJA; Boltje TJ; de Jonge MI; Langereis JD
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.